首页> 外文会议>Annual meeting of the Society for Biomaterials >Mixed Micelles Composed of PEG-lipids and Cytotoxic Peptide Amphiphiles for Cancer Therapy
【24h】

Mixed Micelles Composed of PEG-lipids and Cytotoxic Peptide Amphiphiles for Cancer Therapy

机译:由PEG脂质和细胞毒性肽两亲物组成的混合胶束用于癌症治疗

获取原文

摘要

This work demonstrates that therapeutic peptides can be incorporated into self-assembled micelles with PEG-lipids. The mode of action of the cytotoxic peptide amphiphile was altered depending on how the peptide was displayed to the cells. This results from this work show that PEG-lipids will be able to protect therapeutic peptides during circulation. Previous work has demonstrated that micelles constructed from peptide-PEG-lipids can deliver imaging agents to tumors in vivo. Future work will include targeting peptides at the end of the PEG chains to specifically deliver these therapeutic peptides to cancer in vivo. This platform has the potential to deliver not only D-(KLAKLAK)2 as a therapeutic to many types of cancers, but also provide a blueprint for an effective way to deliver a wide variety of peptide therapeutics to their disease targets.
机译:这项工作表明,治疗性肽可以与PEG-脂质一起掺入自组装胶束中。细胞毒性肽两亲物的作用方式取决于肽向细胞展示的方式而改变。这项工作的结果表明,PEG-脂质将能够在循环过程中保护治疗性肽。先前的工作表明,由肽-PEG-脂质构成的胶束可以在体内将成像剂传递给肿瘤。未来的工作将包括在PEG链末端靶向多肽,以将这些治疗性多肽特异性地体内递送至癌症。该平台不仅有可能提供D-(KLAKLAK)2作为多种癌症的治疗剂,而且还为将多种肽治疗剂提供给其疾病靶标的有效途径提供了一个蓝图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号